BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/6/2016 4:13:00 PM | Browse: 1257 | Download: 2212
 |
Received |
|
2015-05-29 10:17 |
 |
Peer-Review Started |
|
2015-06-01 07:59 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2015-10-05 15:06 |
 |
Revised |
|
2015-10-20 00:42 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2015-11-12 19:00 |
 |
Second Decision by Editor-in-Chief |
|
2015-11-12 22:13 |
 |
Final Decision by Editorial Office Director |
|
2015-12-01 09:03 |
 |
Articles in Press |
|
2015-12-01 09:03 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2015-12-18 10:19 |
 |
Publish the Manuscript Online |
|
2016-01-06 16:13 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Biomarkers of skin toxicity induced by anti-epidermal growth factor receptor antibody treatment in colorectal cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Akiko Kubo, Hironobu Hashimoto, Naoki Takahashi and Yasuhide Yamada |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Naoki Takahashi, MD, Gastrointestinal Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. naoki19800623@gmail.com |
| Key Words |
Colorectal cancer; Skin toxicity; Epidermal growth factor receptor; Epidermal growth factor receptor polymorphism; Ligand |
| Core Tip |
Skin toxicity is a well-known biomarker used in the prognosis of anti-epidermal growth factor receptor (EGFR) antibody treatment of colorectal cancer patients. Previous retrospective studies indicated a change of the polymorphism of EGFR intron-1, chemokines and ligands were predictive markers of skin toxicity induced by anti-EGFR antibody. Such biomarkers used in predicting skin toxicity will enable the earlier management of skin toxicity as well as improve patients’ quality of life; however, further validations of prospective studies are needed. For patients with no/mild skin toxicity, a clinical trial of a dose escalation strategy is under evaluation and ongoing in the form of the EVEREST 2 study. |
| Publish Date |
2016-01-06 16:13 |
| Citation |
Kubo A, Hashimoto H, Takahashi N, Yamada Y. Biomarkers of skin toxicity induced by anti-epidermal growth factor receptor antibody treatment in colorectal cancer. World J Gastroenterol 2016; 22(2): 887-894 |
| URL |
http://www.wjgnet.com/1007-9327/full/v22/i2/887.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v22.i2.887 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.